Snapshot img

US Cannabis Market Size 2025-2029

The US cannabis market size is forecast to increase by USD 141.48 billion at a CAGR of 37.1% between 2024 and 2029.

The US cannabis market is experiencing significant growth, driven by the expanding millennial population in key markets and increasing investment in research and production of medical marijuana. This demographic shift, coupled with growing acceptance of cannabis for medicinal purposes, presents a substantial opportunity for market expansion. From soothing medical treatments to trendy recreational products, cannabis is weaving its way into the fabric of American life, transforming healthcare, leisure, and local economies. However, challenges persist, including accessibility issues and high prices associated with medical cannabis. These obstacles necessitate strategic planning and innovation from industry players to effectively cater to consumer needs and maintain competitiveness.
Companies seeking to capitalize on market opportunities must navigate these challenges, ensuring regulatory compliance and offering competitive pricing and accessibility solutions. By addressing these factors, businesses can effectively position themselves in the dynamic and evolving cannabis market landscape.

What will be the size of the US Cannabis Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The cannabis market in the US is experiencing significant market dynamics and trends, with various entities playing crucial roles. Environmental impact is a pressing concern, as the industry explores sustainable practices, such as water management and energy efficiency, to minimize its carbon footprint. Economic impact is substantial, with tax revenue generation and job creation being key drivers. Regulatory challenges persist, as legal frameworks evolve, addressing issues like intellectual property, data analytics, and drug abuse prevention. Product safety and consumer safety are paramount, with rigorous testing for addictive substances and contaminants. Yield optimization and nutrient solutions are essential for maximizing profits, while cannabis accessories, including dab rigs and vaporizers, cater to diverse consumer preferences.
Waste management and public health concerns are also critical, as the industry navigates the complexities of the legal framework, grey market, and public opinion. Social equity initiatives aim to address historical injustices and promote community impact. Trichome analysis and legalization debates continue, as the industry strives for product standardization and consumer trust. Regulatory compliance, product safety, and sustainability are essential for navigating the evolving cannabis market landscape.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Derivative Type

  CBD
  THC
  Balanced THC and CBD


Product

  Medical
  Recreational


Source

  Marijuana
  Hemp


Cultivation Type

  Indoor Cultivation
  Outdoor Cultivation
  Greenhouse Cultivation


Distribution Channel

  Dispensaries
  Online


Geography

  North America

    US

By Derivative Type Insights

The cbd segment is estimated to witness significant growth during the forecast period.

The CBD segment in the US cannabis market is expected to remain dominant due to the federal legality of hemp-derived CBD oil. This trend is driven by relaxing government norms regarding CBD usage in most states and at the federal level. As of 2024, states like Georgia and Indiana allow hemp-derived CBD oil for medicinal purposes, with Georgia permitting oil containing up to 5% THC for specific medical conditions, and Indiana allowing its use as long as it contains less than 0.3% THC. Quality control and compliance regulations are crucial in the cannabis industry, with potency testing, heavy metal testing, microbial testing, and pesticide testing being essential for ensuring consumer safety.

Extraction methods, such as supercritical fluid extraction and CO2 extraction, play a significant role in the production of CBD isolate, broad-spectrum CBD, and THC oil. Brand development and marketing strategies are essential for businesses looking to succeed in the competitive cannabis market, with product labeling, inventory management, and consumer perception being key factors. The cannabis market encompasses various product offerings, including cannabis edibles, cannabis concentrates, and cannabis cultivation methods like soil cultivation, outdoor growing, and indoor growing. Organic cannabis and child-resistant packaging are also important considerations for businesses. D

The Cannabis Market Report is Segmented by Product Type (Flower, Pre-Rolls, Concentrates, and More), by Application (Medicinal, Adult-Use/Recreational, and More), by Compound Type (THC-Dominant, CBD-Dominant, and More), and by Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Marijuana Market Size 2024-2028

The marijuana market size is forecast to increase by USD 87.8 billion at a CAGR of 32.14% between 2023 and 2028.

The market is experiencing significant growth due to the increasing legalization of cannabis for medical and recreational use in various regions. This trend is further fueled by the expansion of the e-commerce industry, enabling easier access to cannabis-infused edible products, CBD oil, and other cannabinoid-based offerings. However, the market also faces challenges such as the potential side effects associated with inappropriate use of medical marijuana and the need for effective pest control solutions to ensure product quality and safety. The cannabis industry is evolving rapidly, with a focus on innovation and compliance to meet the growing demand for CBD and other cannabinoid-based products.

What will be the Size of the Marijuana Market During the Forecast Period?

Request Free Sample

The market encompasses a diverse range of products derived from the Cannabis plant, including flowers, concentrates, edibles, topicals and tinctures. Two primary types of cannabis are commonly recognized: Cannabis sativa and Cannabis indica. THC (tetrahydrocannabinol) and CBD (cannabidiol) are the most prominent cannabinoids, with THC producing psychoactive effects and CBD offering therapeutic benefits. Medical cannabis and recreational cannabis are the two primary market segments. Medical cannabis is used to alleviate symptoms of various conditions, such as chemotherapy-induced nausea, while recreational cannabis is consumed for its psychoactive properties. CBD products, such as CBD gummies, have gained popularity due to their non-psychoactive nature and potential health benefits.
The market is continually evolving, with new products and innovations emerging regularly. Cannabinoids, including CBD (Epidiolex) and THC (Sativex, Marinol, Syndros, and others), are being developed and marketed as pharmaceuticals. The cannabis market is experiencing significant growth and is expected to continue expanding due to increasing legalization, consumer demand, and ongoing research and development.

How is this Marijuana Industry segmented and which is the largest segment?

The marijuana industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Medical marijuana
  Recreational marijuana


Type

  Oil and tinctures
  Flower


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  APAC



  South America



  Middle East and Africa

By Product Insights

The medical marijuana segment is estimated to witness significant growth during the forecast period. Medical marijuana is experiencing significant growth In the US market due to its potential therapeutic benefits for various health conditions. Chronic pain, including neuropathic and inflammatory pain, is one of the primary conditions treated with marijuana. The increasing prevalence of chronic pain among adults and the popularity of medical marijuana as a pain reliever are driving market expansion. Additionally, medical marijuana has shown promise in alleviating nausea caused by conditions such as Crohn's disease, acute gastritis, hypoglycemia, panic disorder, and arachnoiditis. Marijuana plants used for medicinal purposes include Cannabis indica, Cannabis sativa, and hybrids. The market for medical marijuana products, including flowers, concentrates, edibles, topicals, and tinctures, is expected to continue growing due to their potential therapeutic applications in treating conditions such as epilepsy, multiple sclerosis, anxiety, cancer, glaucoma, and insomnia.

Get a glance at the market report of share of various segments Request Free Sample

The Medical marijuana segment was valued at USD 9.19 billion in 2018 and showed a gradual increase during the forecast period. THC and CBD are the primary cannabinoids found in marijuana, with THC providing psychoactive effects and CBD offering therapeutic benefits without the high. Other cannabinoid-based products, such as Sativex, Marinol, Cesamet, and various cannabis-based products, are also gaining popularity for their medicinal applications. The legalization of marijuana for adult use in some states and continued clinical trials for various conditions are further fueling market growth.

Regional Analysis

North America is estimated to contribute 87% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, the legalization of marijuana for medical use is gaining momentum. In the US and Canada, marijuana is authorized for thera

The Medical Cannabis Market size is expected to reach a valuation of USD 137.9 billion in 2033 growing at a CAGR of 21.90%. The Medical Cannabis Market research report classifies Market by share, trend, demand, forecast and based on segmentation.

Capsules and oils are the most common formulation types in the Medical Cannabis Market, offering precise dosing and ease of administration. Advanced delivery systems, such as transdermal patches and sublingual sprays, are gaining popularity due to their enhanced bioavailability and targeted delivery mechanisms. The increasing demand for non-psychoactive cannabinoids, such as cannabidiol (CBD), is driving the growth of the other formulation types segment. Different application segments cater to specific medical conditions, with chronic pain, arthritis, migraine, and cancer being the most prevalent. Recent developments include: In March 2024, Jesse Ventura introduced a cannabis edible brand. Ventura partnered with Retro Bakery, based in Columbia Heights, to manufacture THC edibles derived from hemp., February 2023: Metrc reported the expansion of its contract with the State of Missouri to support the regulation of its adult-use cannabis market.. Key drivers for this market are: Increasing Number of Countries Legalizing the Use of Medical Marijuana, Trend of Producing Edible Products with Cannabis; Favorable Reimbursement Environment and Government Support in Certain Countries. Potential restraints include: Lack of Awareness about the Dosage and Medicinal Properties of Marijuana, Social Stigma Related to Cannabis Use. Notable trends are: The Chronic Pain Segment is Expected to Experience the Fast Growth Over the Forecast Period.

Global Legal Cannabis Market size is expected to be worth around USD 247.4 Billion by 2033 from USD 26.1 Billion in 2023

Cannabis Market Outlook

According to our latest research, the global cannabis market size reached USD 67.2 billion in 2024, reflecting a robust expansion driven by evolving regulatory environments and increasing consumer acceptance. The market is projected to grow at a CAGR of 14.8% from 2025 to 2033, with the total market value forecasted to reach USD 196.3 billion by 2033. The significant growth momentum is primarily attributed to the rising demand for both medical and recreational cannabis, advancements in product innovation, and broadening legalization across key markets.

One of the primary growth factors for the global cannabis market is the progressive shift in legislative frameworks worldwide. Governments in North America, Europe, and parts of Latin America are increasingly recognizing the therapeutic benefits of cannabis, leading to the relaxation of restrictions and the establishment of regulated markets. Medical cannabis, in particular, has gained traction as scientific studies and clinical trials continue to validate its efficacy in managing chronic pain, neurological disorders, and various other health conditions. This regulatory evolution is not only fueling domestic consumption but also encouraging cross-border investments and collaborations, further accelerating market expansion.

Consumer awareness and acceptance of cannabis-derived products have witnessed a significant surge, contributing to the market's exponential growth. The stigma traditionally associated with cannabis use is gradually diminishing, thanks to extensive educational campaigns, advocacy by patient groups, and endorsements by healthcare professionals. The proliferation of diverse product formats such as edibles, concentrates, topicals, and wellness supplements is attracting a broader demographic, including older adults seeking alternative therapies and younger consumers interested in recreational experiences. This diversification in product offerings is enabling companies to tap into new user segments and sustain long-term growth.

Technological advancements in cultivation, extraction, and product formulation are transforming the cannabis industry landscape. Innovations such as precision agriculture, hydroponics, and advanced extraction techniques are enhancing product quality, consistency, and yield. These improvements are not only resulting in premium-grade cannabis products but are also fostering the development of novel applications across medical, recreational, and industrial sectors. Furthermore, the integration of digital platforms for sales and distribution is streamlining access to legal cannabis, thereby expanding market reach and driving revenue growth.

From a regional perspective, North America continues to dominate the global cannabis market, accounting for the largest share in 2024 due to favorable regulatory policies, high consumer demand, and a well-established supply chain. Europe is emerging as a significant growth frontier, propelled by incremental legalization and rising investments in research and development. Meanwhile, the Asia Pacific region is gradually opening up to cannabis, with countries like Thailand and Australia leading the way in medical cannabis adoption. Latin America and the Middle East & Africa are also witnessing increased activity, although market maturity varies significantly across these regions.

Product Type Analysis

The cannabis market is segmented by product type into flower, concentrates, edibles, topicals, and others. The flower segment remains the most traditional and widely consumed form, particularly among recreational users who prefer smoking or vaporizing. The popularity of cannabis flower is underpinned by its accessibility, affordability, and the immediate effects it delivers. However, the segment is experiencing intense competition from newer product forms as consumer preferences evolve. Companies are investing in premium and specialty strains to differentiate their offerings, while regulatory bodies are introducing qual

The Legal Cannabis Market size was valued at USD 27.4 billion in 2023 and is projected to reach USD 134.36 billion by 2032, exhibiting a CAGR of 25.5 % during the forecasts period. The market under consideration is the legal marijuana industry comprising marijuana production, distribution, and sale for medical marijuana and recreational marijuana usage with the help of governmental permissions. It is used for the purpose of medicinal consumption for some ailments such as chronic pain, epilepsy, and anxiety disorder. The main use is recreational, thus the inclusion of relaxation and social pleasure. It is used in both medical/health products and traditional food products and even in snack foods and drinks, and vapes. Current trends consist of worldwide legalization, a factor that is helping drive the market. As for the product innovations in beverage industry it is also worth mentioning CBD related products and new ways of consuming a product. These are the changes in regulations and growing concern about the effects of marijuana on people, resulting in quality assurance to customers.

Cannabis market is expected to grow from USD 39.21 billion in 2024 to USD 47.76 billion in 2025 and USD 231.81 billion by 2035, representing a CAGR of 17.1%.

Recent developments include: In August 2024, Curaleaf announced the appointment of Executive Chairman Boris Jordan as Chairman and CEO, replacing outgoing CEO Matt Darin, who will retire but remain as a special advisor until year-end. , In July 2024, New York Governor Kathy Hochul announced the state’s efforts to boost the cannabis industry, issuing 109 additional licenses for adult use and reforming regulations to promote responsible growth. , In January 2024, iAnthus Capital Holdings, Inc. partnered with Grön Edibles to bring the renowned, woman-owned edible brand to the New Jersey market, launching Grön’s Sugar-Coated Pearl gummies in state dispensaries. , In January 2024, Acreage Holdings launched its adult-use operations in New York, making its “The Botanist” products available for wholesale purchase to eligible dispensaries. .

Medicinal Cannabis Market valuation is estimated to reach USD 23.93 Bn in 2025 and is anticipated to grow to USD 102.58 Bn by 2032 with steady CAGR of 23.1%.

The US Cannabis Market size is expected to be worth around US$ 115.1 Billion by 2034 from US$ 38.4 Billion in 2024.

The United States medical cannabis market size reached around USD 15.10 Billion in 2024. The market is projected to grow at a CAGR of 12.20% between 2025 and 2034 to reach nearly USD 47.74 Billion by 2034.

Medical cannabis market is expected to grow from USD 21.33 bn in 2024 to reach USD 27.81 bn in 2025 and USD 211.54 bn by 2035, representing a CAGR of 22.5%.

The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.

North America Cannabis Market size, market share, focus on medical application, Distribution Channel, Market Share & North America Cannabis Market Analysis 2025, Market Size, Market Forecast, Market Trends, Market Growth.

Snapshot img

Legal Cannabis Market Size 2025-2029

The legal cannabis market size is forecast to increase by USD 142.39 billion at a CAGR of 31.7% between 2024 and 2029.

The market is experiencing significant growth driven by the increasing number of countries decriminalizing and legalizing cannabis use. This global trend is fueled by a growing recognition of the medicinal benefits of cannabis and shifting societal attitudes towards its use. A key trend in the market is the adoption of advanced techniques in cannabis cultivation, including hydroponics and greenhouse growing, which enable higher yields and improved product quality. However, the cannabis market faces challenges, particularly in the area of funding and investment. Despite its growth potential, the industry remains largely underbanked due to federal regulations in many countries, making it difficult for businesses to secure the capital they need to scale operations and meet demand. Companies seeking to capitalize on market opportunities must navigate these challenges effectively, exploring alternative funding sources and building strong business plans to attract investors. Overall, the market presents significant opportunities for growth, particularly in areas such as medical applications, product innovation, and international expansion.

What will be the Size of the Legal Cannabis Market during the forecast period?

Request Free SampleThe cannabis market encompasses a range of products derived from the cannabis plant, including CBD products. CBD, a non-psychoactive compound, is gaining traction in the medical field for its therapeutic potential in treating conditions such as epilepsy seizures and chemotherapy-induced nausea. Marijuana, a plant containing both CBD and THC, is classified as a Schedule I drug in the US, limiting its availability and use. However, the medical cannabis market is expanding, with pharmacists prescribing it for chronic disease treatment and managing chronic pain. The cultivation techniques used to produce these strains can significantly impact their medicinal properties. CBD and THC derivatives are also being explored for their potential in treating multiple sclerosis and other health conditions. The genetic makeup of the cannabis plant continues to be a focus of research, as scientists uncover new medicinal applications for this versatile plant.

How is this Legal Cannabis Industry segmented?

The legal cannabis industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductMedical cannabisRecreational cannabisDerivative TypeCBDTHCBalanced THC and CBDSourceHempMarijuanaGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKMiddle East and AfricaAPACAustraliaChinaIndiaJapanSouth AmericaRest of World (ROW)

By Product Insights

The medical cannabis segment is estimated to witness significant growth during the forecast period.The medical cannabis market encompasses the utilization of cannabis and its derivatives for therapeutic applications. This segment holds significance due to the potential therapeutic benefits it offers for various medical conditions and symptoms. Medical cannabis is commonly employed to alleviate chronic pain, reduce inflammation, manage nausea and vomiting, stimulate appetite, and provide relief for symptoms related to diseases such as multiple sclerosis, epilepsy, cancer, and HIV or AIDS. Furthermore, it is being investigated for its potential therapeutic effects on mental health disorders, including anxiety, depression, and PTSD. Medical cannabis is available in different forms, including cannabis flower, extracts, tinctures, and edibles. The legalization of cannabis for medical use has led to the development of eco-friendly packaging solutions and the emergence of online platforms for sales. However, the market faces challenges such as illegitimate trade, social stigma, and regulatory complexities. The therapeutic potential of cannabis is attributed to its cannabinoid content, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC). The medical field continues to explore the medicinal properties of cannabis and its species, Cannabis Sativa and Cannabis Indica, to address the unmet needs of patients. Pharmacists, medical practitioners, and state governments play crucial roles in ensuring the safe and effective use of medical cannabis. Despite the ongoing debates surrounding cannabis, its legitimization for medical use has gained momentum, with an increasing number of adults recognizing its health benefits. The market for medical cannabis products, including CBD, is expected to grow as more research is conducted on its therapeutic potential and its use becomes more mainstream.

Get a glance at the market report of share of various segments Request Free Sampl

The cannabis market was valued at USD 33.70 Billion in 2024. It is expected to grow at a CAGR of 15.20% during the forecast period 2025-2034. The market is further expected to reach a market value of approximately USD 138.72 Billion by 2034.

The global cannabis pharmaceuticals market, valued at $1.319 billion in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2025 to 2033. This expansion is driven by several key factors. Increasing prevalence of chronic pain conditions, coupled with the limitations and side effects of traditional pharmaceutical treatments, fuels demand for alternative therapies like cannabis-based medications. Furthermore, growing scientific research validating the therapeutic potential of cannabinoids in managing various ailments, including epilepsy, multiple sclerosis, and certain types of cancer, contributes significantly to market growth. The rising acceptance and legalization of medical cannabis in numerous countries are also major catalysts, expanding market access and driving investment in research and development. While regulatory hurdles and potential safety concerns remain restraints, the innovative product development in various forms, including sprays, capsules, and tablets, is countering these challenges and diversifying market offerings to cater to patient preferences. Pharmacies and hospitals are leading application segments, reflecting the increasing integration of cannabis-based medicines into mainstream healthcare systems. Major market players like Cronos Group, Jazz Pharmaceuticals, and Tilray Brands are actively shaping the market through strategic collaborations, clinical trials, and product launches. Geographic expansion is also a key factor, with North America currently dominating the market, but significant growth anticipated in other regions as legalization efforts and public awareness increase. The market segmentation reveals promising avenues for future growth. The sprays segment is experiencing rapid growth due to its quick onset of action and ease of administration. Meanwhile, the capsules and tablets segments are expected to maintain stable growth, reflecting the increasing preference for convenient and discreet dosage forms. The "Others" category presents emerging opportunities as research continues to uncover the therapeutic potential of various cannabinoids and their delivery methods. Regionally, North America is leading the market due to its early adoption of medical cannabis and well-established regulatory frameworks. However, Europe and Asia Pacific show significant potential for growth, driven by supportive governmental policies and increasing acceptance of cannabis-based therapies in these regions. The continued focus on research and development, coupled with the evolving regulatory landscape, will play a crucial role in shaping the trajectory of this dynamic market in the coming years.

The Australia Legal Cannabis Market size was valued at USD 123.9 million in 2023 and is projected to reach USD 689.90 million by 2032, exhibiting a CAGR of 27.8 % during the forecasts period. Legal Cannabis refers to the cultivation, distribution, and use of cannabis products within the confines of the law. It encompasses various forms of the cannabis plant, including marijuana and hemp, which are cultivated and sold for recreational or medicinal purposes. One of its prominent features is the regulation imposed by governing bodies to ensure quality control and safety standards are maintained, unlike in illegal markets. Legal Cannabis offers several advantages. It generates revenue through taxation, contributing to government funds and potentially alleviating financial burdens. It promotes consumer safety by providing access to regulated products with known potency and purity. Additionally, it reduces the burden on law enforcement, allowing them to focus on more pressing issues. Recent developments include: In February 2024, Peak Processing Solutions, an Althea Group Holdings subsidiary, signed an agreement with Collective Project to produce 6 cannabis-based beverage products based on contract manufacturing. , In January 2024, Althea Group Holdings Limited, a manufacturer and distributor of cannabis-based products, launched two new products, Althea THC10, and Althea CBD3:THC2, and expanded its softgel capsule product range. , In June 2023, Cann Group Limited signed an agreement with Levin Health Pty Ltd., to supply cannabis flowers to Levin to meet the production of cannabis based products. .